Merck, a leading science and technology company, today announced new data from a number of high priority clinical development programs across its oncology portfolio to be presented at this year's American Society of Clinical Oncology Annual Meeting (ASCO), June 1-5, 2018, Chicago. Abstracts representing seven therapeutic agents and eight tumor types will highlight Merck's position as a key emerging player in oncology.
Source:
prnewswire.com/news-releases/merck-data-at-asco-2018-to-showcase-progress-and-further-optionality-of-oncology-pipeline-300650091.html
Source:
prnewswire.com/news-releases/merck-data-at-asco-2018-to-showcase-progress-and-further-optionality-of-oncology-pipeline-300650091.html
No comments:
Post a Comment